Free Access
Issue
J Extra Corpor Technol
Volume 42, Number 4, December 2010
Page(s) 281 - 285
DOI https://doi.org/10.1051/ject/201042281
Published online 15 December 2010
  1. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144. [Google Scholar]
  2. Jones KW, Cain AS, Mitchell JH, et al. Hyperglycemia predicts mortality after CABG: Postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J Diabetes Complications. 2008;22:365–70. [CrossRef] [PubMed] [Google Scholar]
  3. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67. [CrossRef] [PubMed] [Google Scholar]
  4. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons Practice Guideline Series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663–9. [CrossRef] [Google Scholar]
  5. Goldberg PA, Bozzo JE, Thomas PG, et al. “Glucometrics”—assessing the quality of inpatient glucose management. Diabetes Technol Ther. 2006;8:560–9. [CrossRef] [PubMed] [Google Scholar]
  6. Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004;77:151–7. [CrossRef] [Google Scholar]
  7. Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg. 2002;73:538–45. [CrossRef] [Google Scholar]
  8. Zhang R, Kofidis T, Kamiya H, et al. Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients. Eur J Cardiothorac Surg. 2006;30:617–20. [CrossRef] [Google Scholar]
  9. Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36:1404–11. [CrossRef] [PubMed] [Google Scholar]
  10. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006;27:2716–24. [CrossRef] [PubMed] [Google Scholar]
  11. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61. [CrossRef] [PubMed] [Google Scholar]
  12. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH. Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190–7. [CrossRef] [PubMed] [Google Scholar]
  13. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39. [CrossRef] [PubMed] [Google Scholar]
  14. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97. [CrossRef] [PubMed] [Google Scholar]
  15. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA. 2008;300:933–44. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.